As per the research report, the Asia Pacific Microbial Identification Market size is calculated to approach USD 0.39 billion by 2027 with a CAGR of 6.80%, from the 2022 valuation of USD 0.28 billion during the forecast period 2022 to 2027.
The rising prevalence of infectious diseases and the increasing frequency of pandemics, technical improvements, rising food safety concerns, and increased government activities and funding to detect and control antimicrobial-resistant species are driving growth in this market. Microbiological advancements have been at the forefront of the microbial identification market's growth.
The demand for detailed information about numerous diseases and their causes has driven the microbial identification market to new heights. In addition, the study of microbiological characterization, which includes colony shape, Gram stain, and Catalase, among other things, has also opened up new business prospects. Microbial identification encompasses both phenotypic and genotypic identification.
In addition, the employment of multiple modules for organism classification has aided in defining the concept of microbiological identification. The pharmaceutical industry's success and value are characterized by its ability to respond to problems that occur in modern medicine. As a result, microbial identification has been embraced by the pharmaceutical industry as a means of fostering innovation in medication development and research.
Pharmaceutical companies are also interested in using microbial identification to investigate the effects of various medications on specific microorganisms. As a result, the Asia Pacific microbial identification market's total revenue is expected to expand significantly. In addition, microbial identification is closely linked to human DNA and how it differs from that of other species.
The pandemic and statewide lockdowns have caused a drop in sales of these products. In addition, most countries are significant manufacturers of the instruments and consumables used for microbiological identification, which harms the market for microbial identification. As a result, it is difficult for automated microbial identification techniques to be widely adopted, especially by smaller institutions.
This research report on the APAC Microbial Identification Market has been segmented and sub-segmented into the following categories:
By End User:
Geographically, the Asia Pacific is the fastest-growing region due to the increased attention of major players in emerging Asian countries and government assistance.
The China microbial identification market is predicted to grow fastest due to rising consumer concerns about food safety and health. Furthermore, government initiatives to prevent food and water contamination have aided the sector over time.
The Indian microbial identification market is witnessing significant growth due to rising demand for these products in biotechnology and pharmaceutical businesses, research institutes, and blood banks.
The Japan microbial identification market is predicted to earn the most revenue in the APAC region over the forecast period due to improving healthcare infrastructure, a high burden of infectious diseases, growing measures to control infectious diseases, and increased investments by key companies in the region.
KEY MARKET PLAYERS
The Top companies leading in the APAC Microbial Identification Market profiled in the report are Shimadzu Corporation, Dickinson & Company, Biolog Inc., Trivitron Healthcare, Thermo Fisher Scientific Inc., Charles River Laboratories International Inc, Bruker Corporation, VWR Corporation, Merck KGaA, IEH Laboratories & Consulting Group.,
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.5 Y-o-Y Growth Analysis, By Method
5.1.6 Market Attractiveness Analysis, By Method
5.1.7 Market Share Analysis, By Method
5.2.6 Y-o-Y Growth Analysis, By Application
5.2.7 Market Attractiveness Analysis, By Application
5.2.8 Market Share Analysis, By Application
5.3.2 Identification Services
5.3.5 Y-o-Y Growth Analysis, By Products and Services
5.3.6 Market Attractiveness Analysis, By Products and Services
5.3.7 Market Share Analysis, By Products and Services
5.4 End User
5.4.1 Food Manufacturing Industries
5.4.2 Pharmaceutical Companies
5.4.3 Hospitals and Diagnostic Centres
5.4.4 Other End users
5.3.5 Y-o-Y Growth Analysis, By End User
5.3.6 Market Attractiveness Analysis, By End User
5.3.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Method
184.108.40.206 By Application
220.127.116.11 By Product
18.104.22.168 By End User
6.1.4 Market Attractiveness Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Method
188.8.131.52 By Application
184.108.40.206 By Product
220.127.116.11 By End user
6.1.5 Market Share Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Method
126.96.36.199 By Application
188.8.131.52 By Product
184.108.40.206 By End user
6.2.6 South Korea
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Shimadzu Corporation
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Dickinson & Company
8.3 Biolog Inc.
8.4 Merck KGaA
8.5 IEH Laboratories & Consulting Group
8.6 Trivitron Healthcare
8.7 Laboratory Corporation of America Holdings
8.8 Thermo Fisher Scientific Inc.
8.9 Bruker Corporation
8.10 Charles River Laboratories
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.